METRICS IN BALANCE overview

EQS Group-Media / 08.07.2021 / 15:45 Gent, Belgium --(EQS)-- Metrics in Balance (EURONEXT: MLMIB, ISIN BE0974328602) , a clinical-diagnosis Company or "Metrics in Balance" or "MIB" or "the Company" is proud to provide investors with an update in the Company's business development. "The Company has started to sell DNA-kits helping clients achieve a better lifestyle. Together with blood tests we could make a patient's DNA actionable with personalized treatment plans ultimately setting up...

EQS Group-Media / 19.01.2021 / 13:29 Gent, Belgium--(EQS)-Metrics in Balance (EURONEXT: MLMIB, ISIN BE0974328602) , a clinical-diagnosis company announced today that it will apply for a secondary listing on the Börse Stuttgart (SWB). "We are excited to target trading on the Börse Stuttgart, the second largest stock exchange in Germany. This will broaden our reach in the European capital markets, and allows easier trading for our German shareholders. We are proud to provide another route for...